• No se han encontrado resultados

TítuloLeukocyte telomere length in patients with radiographic knee osteoarthritis

N/A
N/A
Protected

Academic year: 2020

Share "TítuloLeukocyte telomere length in patients with radiographic knee osteoarthritis"

Copied!
7
0
0

Texto completo

Loading

Figure

Table 1. Statistical Values of Mean Telomere Length (measured as T/S ratio) in Peripheral Blood Leukocytes from  Subjects without Knee Osteoarthritis (OA), that is, Maximum Radiologic Kellgren–Lawrence (max‐KL) Grade 0 or 1, and  with Progressive Severity
Table 3. Logistic Regression Analysis of the Association of PBL Telomere Size and Habitual Health Parameters with  Concurrent Knee Osteoarthritis

Referencias

Documento similar

To explore the factors associated with the range of motion 45 days after reimplantation, a multiple linear regression was performed, considering the type of spacer used as an

Introduction: The aim of this study was to analyze functional results and range of motion and compare them between three groups of patients with total knee arthroplasty: two

Study inclusion criteria were: patients with advanced knee Osteoarthritis, associated or not with nonunion, who had undergone TKA, with a history of knee fracture (distal femoral

As it is shown in the Table  4, in the raw model, frailty was cross-sectionally associated with higher risk of hos- pitalization, mean length of stay (the log-count of aver- age

All together, these results indicate that mice and cells doubly deficient for PMS2 and telomerase show severe telomere dysfunction as indicated by similar frequencies of ␥-H2AX foci,

28 Without elective hip and knee arthroplasty procedures, our patients are at risk of increased pain and less mobility, and our health care institutions are at risk of

In addition, GBM are also highly heterogeneous tumors (Soeda et al. 2015), which highlights the importance of targeting telomeres independently of telomere length,

These GCP statements suggest: treatment should achieve clinical improvement bringing the patient to the Patient Acceptable Symptom State (PASS); pharmacological and